HAP's Latest News

Advocates for Medical Research Call for NIH Investments

September 16, 2020

A broad coalition of medical research advocates, including researchers and stakeholders representing more than 300 organizations and institutions including HAP, are urging Congress to make funding the National Institutes of Health (NIH) a national priority.

Advocates are calling on federal lawmakers to invest in medical research in order to support life-saving and life-changing medical research to combat deadly diseases and debilitating chronic conditions. They emphasized that the COVID-19 pandemic has shed light on the importance of NIH-supported investments in research and cutting-edge science as the world has faced this global public health crisis. Advocates also are urging Congress to fund medical research that has been delayed and critical COVID-19 research; as well as to exempt the NIH from highly restrictive fiscal year (FY) 2021 budget caps, in order to better respond to the pandemic.  



Medical schools and teaching hospitals in Pennsylvania are conducting medical research that has led to groundbreaking advancements, including for the prevention and treatment of COVID-19.  

During FY 2019, federal research funding through the NIH supported $1.94 billion in total funds awarded to 3,848 grantees at 116 research sites in Pennsylvania. California, Massachusetts, New York, and Pennsylvania are the leading states in the award of NIH grant funding.  

Throughout this year, medical research advocates have called for a $2.6 billion increase to the NIH budget.

HAP urges federal lawmakers to make investments to drive research surrounding COVID, support new cures and medical innovations, and foster positive economic development by swiftly enacting the proposed $2.6 billion increase in NIH funding.

For more information, contact Laura Stevens Kent, HAP’s vice president, federal advocacy, with questions.